
Veritas Capital has agreed to buy DXC Technology’s (NYSE: DXC) U.S. state and local health and human services business for $5B in cash. The transaction is expected to be completed by December, subject to regulatory approvals, receipt of third-party consents and other customary closing conditions, DXC said Tuesday....